Methylprednisolone and Linagliptin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Methylprednisolone (methylprednisolone) and Linagliptin (linagliptin). Common drug interactions include gout among females and nephritis among males.

The phase IV clinical study analyzes what interactions people have when they take Methylprednisolone and Linagliptin. It is created by eHealthMe based on reports of 39 people who take the same drugs from the FDA, and is updated regularly.

What is Methylprednisolone?

Methylprednisolone has active ingredients of methylprednisolone. It is often used in inflammation. eHealthMe is studying from 59,645 Methylprednisolone users. Check the latest studies of Methylprednisolone.

What is Linagliptin?

Linagliptin has active ingredients of linagliptin. eHealthMe is studying from 8,112 Linagliptin users. Check the latest studies of Linagliptin.

On Jul, 10, 2026

39 people who take Methylprednisolone and Linagliptin together, and have interactions are studied.

Methylprednisolone and Linagliptin drug interactions.

What are the common drug interactions of Methylprednisolone and Linagliptin, by gender? *:

female:

Gout (uric acid crystals building up in the body)
Headache (pain in head)
Hypertension (high blood pressure)
Insomnia (sleeplessness)
Malaise (a feeling of general discomfort or uneasiness)
Metastases to liver (cancer spreads to liver)
Myalgia (muscle pain)
Nausea (feeling of having an urge to vomit)
Osteoporosis (bones weak and more likely to break)
Pain in extremity

male:

Nephritis (inflammation of the nephrons in the kidneys)
Constipation
Folliculitis (infection of hair root)
Herpes simplex (herpes simplex is a common viral infection)
Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
Oral candidiasis (fungal infection of mouth)
Oral herpes (viral infection of mouth)
Rash maculo-papular (red area on the skin that is covered with small confluent bumps)
Thrombocytopenia (decrease of platelets in blood)
White blood cell count decreased

What are the common drug interactions of Methylprednisolone and Linagliptin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Blood creatinine increased
Kidney transplant rejection
Pneumonia
Pyrexia (fever)
Respiratory tract infection

50-59:

Nephritis (inflammation of the nephrons in the kidneys)
Abdominal pain
Chorioretinopathy (collection of fluid under the retina that results in visual distortion)
Cytomegalovirus infection
Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)

60+:

Constipation
Blood creatinine increased
Glomerular filtration rate decreased
Glycosylated haemoglobin increased
Hepatic failure (liver failure)
Intervertebral disc protrusion (spinal disc protrusion)
Leukopenia (less number of white blood cells in blood)
Malignant neoplasm progression (cancer tumour came back)
Menopausal symptoms
Pneumonitis (inflammation of the walls of the alveoli in the lungs)

What are the existing conditions these people have? *

High Blood Pressure: 13 people, 33.33%
Diabetes: 12 people, 30.77%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 7 people, 17.95%
High Blood Cholesterol: 5 people, 12.82%
Rashes (redness): 5 people, 12.82%
Diarrhea: 5 people, 12.82%
Vasculitis (inflammation of a blood vessel or blood vessels): 4 people, 10.26%
Gout (uric acid crystals building up in the body): 4 people, 10.26%
Constipation: 4 people, 10.26%
Insomnia (sleeplessness): 3 people, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Methylprednisolone and Linagliptin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously